Minimal-length short hairpin RNAs: The relationship of structure and RNAi activity

  1. Qing Ge1,3,
  2. Heini Ilves1,
  3. Anne Dallas1,
  4. Pavan Kumar1,
  5. Joshua Shorenstein1,
  6. Sergei A. Kazakov1 and
  7. Brian H. Johnston1,2
  1. 1SomaGenics, Inc., Santa Cruz, California 95060, USA
  2. 2Department of Pediatrics, Stanford University School of Medicine, Stanford, California 94305, USA
  • 3 Present address: Department of Immunology, Peking University Health Science Center, Beijing 100191, People's Republic of China.

Abstract

Small hairpin RNAs (shRNAs) are widely used in RNAi studies and typically consist of a stem of 19–29 base pairs (bp), a loop of at least 4 nucleotides (nt), and a dinucleotide overhang at the 3′ end. Compared with shRNAs with 21–29 bp stems, we have found that shRNAs with 19-bp or shorter stems (sshRNAs) possess some unique structure–activity features that depend on whether the antisense strand is positioned 5′ or 3′ to the loop (L- or R-type sshRNAs, respectively). L sshRNAs can have IC50s in the very low picomolar range, and sshRNAs with nominal loop sizes of 1 or 4 nt were at least as active as those with longer loops. L sshRNAs remained highly potent even when the 3′ end of the antisense strand was directly linked with the 5′ end of the sense strand. In this case, the sense strand can be shorter than the antisense strand, and the loop can be formed entirely by the 3′ end of the antisense strand. Monomer sshRNAs are not processed by recombinant Dicers in vitro. Although they can form dimers that are sometimes Dicer substrates, their RNAi activity is not dependent on the formation of such structures. Our findings have implications for the mechanism of action of sshRNAs, and the ability to design highly potent shRNAs with minimal length is encouraging for the prospects of the therapeutic use of direct-delivered shRNAs.

Keywords:

Keywords

Footnotes

  • Reprint requests to: Qing Ge, SomaGenics, Inc., 2161 Delaware Avenue, Santa Cruz, CA 95060, USA; e-mail: qge{at}somagenics.com; fax: (831) 420-0685; or Brian H. Johnston, SomaGenics, Inc., 2161 Delaware Avenue, Santa Cruz, CA 95060, USA; e-mail address: bjohnston{at}somagenics.com; fax: (831) 420-0685.

  • Article published online ahead of print. Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.1894510.

    • Received August 24, 2009.
    • Accepted September 27, 2009.

Related Article

| Table of Contents